Skip to main content
SpringerLink
Log in

Can Patients with Known Intracranial and Intraspinal Vascular Lesions Be Anticoagulated?

  • Chapter
  • First Online:
Anticoagulation and Hemostasis in Neurosurgery

  • 1227 Accesses

Abstract

Known intracranial and intraspinal vascular lesions are a particularly difficult problem to manage due to their wide range in behavior, from the completely benign to the emergently malignant. That, along with the relative rarity of most of the lesions, makes it challenging to develop any evidence-based guidelines for their direct management, not to mention the management of secondary issues that arise, or unrelated medical issues whose treatment could have a major repercussion on the stability of a given lesion.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B. Oxford Centre for Evidence-based Medicine-levels of evidence (March 2009). Centre for Evidence Based Medicine Web site. 1998.

    Google Scholar 

  2. Lasjaunias P. A revised concept of the congenital nature of cerebral arteriovenous malformations. Interv Neuroradiol. 1997;3(4):275–81.

    CAS  PubMed  Google Scholar 

  3. Brown Jr RD, Wiebers DO, Torner JC, O’Fallon WM. Incidence and prevalence of intracranial vascular malformations in Olmsted county, Minnesota, 1965 to 1992. Neurology. 1996;46(4):949–52.

    Article  PubMed  Google Scholar 

  4. Al-Shahi R, Bhattacharya JJ, Currie DG, et al. Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish intracranial vascular malformation study (SIVMS). Stroke. 2003;34(5):1163–9.

    Article  PubMed  Google Scholar 

  5. Wyburn-Mason R. Arteriovenous aneurysm of mid-brain and retina, facial naevi and mental changes. Brain. 1943;66(3):163–203.

    Article  Google Scholar 

  6. Lasjaunias PL, Chng SM, Sachet M, Alvarez H, Rodesch G, Garcia-Monaco R. The management of vein of galen aneurysmal malformations. Neurosurgery. 2006;59(5 Suppl 3):S184–94. discussion S3–13.

    PubMed  Google Scholar 

  7. Mohr J, Parides MK, Stapf C, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet. 2014;383(9917):614–21.

    Article  CAS  PubMed  Google Scholar 

  8. Duong D, Hartmann A, Isaacson S, et al. Arteriovenous malformations of the brain in adults. N Engl J Med. 1999;340(23):1812–8.

    Article  Google Scholar 

  9. Brown RD, Flemming KD, Meyer FB, Cloft HJ, Pollock BE, Link MJ. Natural history, evaluation, and management of intracranial vascular malformations. Mayo Clin Proc. 2005;80(2):269–81.

    Article  PubMed  Google Scholar 

  10. Gross BA, Du R. Natural history of cerebral arteriovenous malformations: a meta-analysis: clinical article. J Neurosurg. 2013;118(2):437–43.

    Article  PubMed  Google Scholar 

  11. da Costa L, Wallace MC, Ter Brugge KG, O’Kelly C, Willinsky RA, Tymianski M. The natural history and predictive features of hemorrhage from brain arteriovenous malformations. Stroke. 2009;40(1): 100–5.

    Article  PubMed  Google Scholar 

  12. Yamada S, Takagi Y, Nozaki K, Kikuta K, Hashimoto N. Risk factors for subsequent hemorrhage in patients with cerebral arteriovenous malformations. J Neurosurg. 2007;107(5):965–72.

    Article  PubMed  Google Scholar 

  13. Stapf C, Mast H, Sciacca RR, et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66(9):1350–5.

    Article  CAS  PubMed  Google Scholar 

  14. Choi JH, Mast H, Sciacca RR, et al. Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke. 2006;37(5):1243–7.

    Article  PubMed  Google Scholar 

  15. Hartmann A, Mast H, Mohr JP, et al. Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke. 1998;29(5): 931–4.

    Article  CAS  PubMed  Google Scholar 

  16. Edwards CP, Shehata N, Faughnan ME. Hereditary hemorrhagic telangiectasia patients can tolerate anticoagulation. Ann Hematol. 2012;91(12):1959–68.

    Article  CAS  PubMed  Google Scholar 

  17. Devlin HL, Hosman AE, Shovlin CL. Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia. N Engl J Med. 2013;368(9):876–8.

    Article  CAS  PubMed  Google Scholar 

  18. Gross BA, Lin N, Du R, Day AL. The natural history of intracranial cavernous malformations. Neurosurg Focus. 2011;30(6):E24.

    Article  PubMed  Google Scholar 

  19. Ramirez-Zamora A, Biller J. Brainstem cavernous malformations: a review with two case reports. Arq Neuropsiquiatr. 2009;67(3B):917–21.

    Article  PubMed  Google Scholar 

  20. Batra S, Lin D, Recinos PF, Zhang J, Rigamonti D. Cavernous malformations: natural history, diagnosis and treatment. Nat Rev Neurol. 2009;5(12): 659–70.

    Article  PubMed  Google Scholar 

  21. Porter PJ, Willinsky RA, Harper W, Wallace MC. Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage. J Neurosurg. 1997;87(2): 190–7.

    Article  CAS  PubMed  Google Scholar 

  22. Robinson JR, Awad IA, Little JR. Natural history of the cavernous angioma. J Neurosurg. 1991;75(5): 709–14.

    Article  CAS  PubMed  Google Scholar 

  23. Moriarity JL, Wetzel M, Clatterbuck RE, et al. The natural history of cavernous malformations: a prospective study of 68 patients. Neurosurgery. 1999;44(6):1166–71.

    PubMed  Google Scholar 

  24. Kondziolka D, Lunsford LD, Kestle JR. The natural history of cerebral cavernous malformations. J Neurosurg. 1995;83(5):820–4.

    Article  CAS  PubMed  Google Scholar 

  25. Aiba T, Tanaka R, Koike T, Kameyama S, Takeda N, Komata T. Natural history of intracranial cavernous malformations. J Neurosurg. 1995;83(1):56–9.

    Article  CAS  PubMed  Google Scholar 

  26. Haasdijk RA, Cheng C, Maat-Kievit AJ, Duckers HJ. Cerebral cavernous malformations: from molecular pathogenesis to genetic counselling and clinical management. Eur J Hum Genet. 2012;20(2): 134–40.

    Article  CAS  PubMed  Google Scholar 

  27. Labauge P, Denier C, Bergametti F, Tournier-Lasserve E. Genetics of cavernous angiomas. Lancet Neurol. 2007;6(3):237–44.

    Article  CAS  PubMed  Google Scholar 

  28. Pozzati E, Zucchelli M, Marliani AF, Riccioli LA. Bleeding of a familial cerebral cavernous malformation after prophylactic anticoagulation therapy: case report. Neurosurg Focus. 2006;21(1):1–3.

    Google Scholar 

  29. Schneble HM, Soumare A, Herve D, et al. Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations. Stroke. 2012;43(12):3196–9.

    Article  CAS  PubMed  Google Scholar 

  30. Chibbaro S, Tacconi L. Safety of deep venous thrombosis prophylaxis with low-molecular-weight heparin in brain surgery. prospective study on 746 patients. Surg Neurol. 2008;70(2):117–21.

    Article  PubMed  Google Scholar 

  31. Awad IA, Little JR, Akrawi WP, Ahl J. Intracranial dural arteriovenous malformations: factors predisposing to an aggressive neurological course. J Neurosurg. 1990;72(6):839–50.

    Article  CAS  PubMed  Google Scholar 

  32. Brown Jr RD, Wiebers DO, Nichols DA. Intracranial dural arteriovenous fistulae: angiographic predictors of intracranial hemorrhage and clinical outcome in nonsurgical patients. J Neurosurg. 1994;81(4):531–8.

    Article  PubMed  Google Scholar 

  33. Borden JA, Wu JK, Shucart WA. A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment. J Neurosurg. 1995;82(2):166–79.

    Article  CAS  PubMed  Google Scholar 

  34. Cognard C, Gobin YP, Pierot L, et al. Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage. Radiology. 1995;194(3):671–80.

    Article  CAS  PubMed  Google Scholar 

  35. van Dijk JM, ter Brugge KG, Willinsky RA, Wallace MC. Clinical course of cranial dural arteriovenous fistulas with long-term persistent cortical venous reflux. Stroke. 2002;33(5):1233–6.

    Article  PubMed  Google Scholar 

  36. Simon S, Yao T, Ulm AJ, Rosenbaum BP, Mericle RA. Dural arteriovenous fistulas masquerading as dural sinus thrombosis. J Neurosurg. 2009;110(3): 514–7.

    Article  PubMed  Google Scholar 

  37. San Millán Ruíz D, Yilmaz H, Gailloud P. Cerebral developmental venous anomalies: current concepts. Ann Neurol. 2009;66(3):271–83.

    Article  Google Scholar 

  38. Hon JM, Bhattacharya JJ, Counsell CE, et al. The presentation and clinical course of intracranial developmental venous anomalies in adults: a systematic review and prospective, population-based study. Stroke. 2009;40(6):1980–5.

    Article  PubMed  Google Scholar 

  39. Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke. 1998;29(1):251–6.

    Article  CAS  PubMed  Google Scholar 

  40. Brown Jr RD, Broderick JP. Unruptured intracranial aneurysms: epidemiology, natural history, management options, and familial screening. Lancet Neurol. 2014;13(4):393–404.

    Article  PubMed  Google Scholar 

  41. Gunda B, Mine M, Kovács T, et al. COL4A2 mutation causing adult onset recurrent intracerebral hemorrhage and leukoencephalopathy. J Neurol. 2014;261(3):500–3.

    Article  PubMed  Google Scholar 

  42. Wermer MJ, van der Schaaf IC, Algra A, Rinkel GJ. Risk of rupture of unruptured intracranial aneurysms in relation to patient and aneurysm characteristics: an updated meta-analysis. Stroke. 2007;38(4): 1404–10.

    Article  PubMed  Google Scholar 

  43. Wiebers DO, International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003;362(9378):103–10.

    Article  PubMed  Google Scholar 

  44. Tarlov N, Norbash AM, Nguyen TN. The safety of anticoagulation in patients with intracranial aneurysms. J Neurointerv Surg. 2013;5(5):405–9.

    Article  PubMed  Google Scholar 

  45. Rinkel GJ, Prins NE, Algra A. Outcome of aneurysmal subarachnoid hemorrhage in patients on anticoagulant treatment. Stroke. 1997;28(1):6–9.

    Article  CAS  PubMed  Google Scholar 

  46. McCormick WF, Hardman JM, Boulter TR. Vascular malformations (“angiomas”) of the brain, with special reference to those occurring in the posterior fossa. J Neurosurg. 1968;28(3):241–51.

    Article  CAS  PubMed  Google Scholar 

  47. Awad IA, Robinson Jr JR, Mohanty S, Estes ML. Mixed vascular malformations of the brain: clinical and pathogenetic considerations. Neurosurgery. 1993;33(2):179–88.

    Article  CAS  PubMed  Google Scholar 

  48. Metso TM, Metso AJ, Helenius J, et al. Prognosis and safety of anticoagulation in intracranial artery dissections in adults. Stroke. 2007;38(6):1837–42.

    Article  CAS  PubMed  Google Scholar 

  49. Kim BM, Kim SH, Kim DI, et al. Outcomes and prognostic factors of intracranial unruptured vertebrobasilar artery dissection. Neurology. 2011; 76(20):1735–41.

    Article  CAS  PubMed  Google Scholar 

  50. Sikkema T, Uyttenboogaart M, Eshghi O, et al. Intracranial artery dissection. Eur J Neurol. 2014;21(6):820–6.

    Article  CAS  PubMed  Google Scholar 

  51. Arnold M, Bousser MG, Baumgartner RW. Prognosis and safety of anticoagulation in intracranial artery dissections in adults. Stroke. 2007; 38(11):e140. author reply e141.

    Article  PubMed  Google Scholar 

  52. Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7(11):1056–66.

    Article  PubMed  Google Scholar 

  53. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12): 1226–37.

    Article  CAS  PubMed  Google Scholar 

  54. Miskinyte S, Butler MG, Hervé D, et al. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Human Genet. 2011;88(6):718–28.

    Article  CAS  Google Scholar 

  55. Herve D, Touraine P, Verloes A, et al. A hereditary moyamoya syndrome with multisystemic manifestations. Neurology. 2010;75(3):259–64.

    Article  CAS  PubMed  Google Scholar 

  56. Kobayashi E, Saeki N, Oishi H, Hirai S, Yamaura A. Long-term natural history of hemorrhagic type moyamoya disease in 42 patients. J Neurosurg. 2000;93(6):976–80.

    Article  CAS  PubMed  Google Scholar 

  57. Gross BA, Du R. The natural history of moyamoya in a North American adult cohort. J Clin Neurosci. 2013;20(1):44–8.

    Article  PubMed  Google Scholar 

  58. Fung LW, Thompson D, Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst. 2005;21(5):358–64.

    Article  PubMed  Google Scholar 

  59. Virchow RLK. Die krankhaften geschwülste, vol. 2. Berlin: A. Hirschwald; 1865.

    Google Scholar 

  60. Jahan R, Vinuela F. Vascular anatomy, pathophysiology, and classification of vascular malformations of the spinal cord. Semin Cerebrovasc Dis Stroke. 2002;2(3):186–200.

    Article  Google Scholar 

  61. Kendall B, Logue V. Spinal epidural angiomatous malformations draining into intrathecal veins. Neuroradiology. 1977;13(4):181–9.

    Article  CAS  PubMed  Google Scholar 

  62. Spetzler RF, Detwiler PW, Riina HA, Porter RW. Modified classification of spinal cord vascular lesions. J Neurosurg Spine. 2002;96(2):145–56.

    Article  Google Scholar 

  63. Aminoff MJ. Spinal angiomas. Oxford: Wiley-Blackwell; 1976.

    Google Scholar 

  64. Thron AK, Rossberg C. Vascular anatomy of the spinal cord: neuroradiological investigations and clinical syndromes. New York: Springer Science & Business Media; 1988.

    Book  Google Scholar 

  65. Gueguen B, Merland JJ, Riche MC, Rey A. Vascular malformations of the spinal cord: intrathecal perimedullary arteriovenous fistulas fed by medullary arteries. Neurology. 1987;37(6):969–79.

    Article  CAS  PubMed  Google Scholar 

  66. Spetzger U, Gilsbach J, Bertalanffy H. Cavernous angiomas of the spinal cord clinical presentation, surgical strategy, and postoperative results. Acta Neurochir. 1995;134(3–4):200–6.

    Article  CAS  PubMed  Google Scholar 

  67. Saladino A, Atkinson JL, Rabinstein AA, et al. Surgical treatment of spinal dural arteriovenous fistulae: a consecutive series of 154 patients. Neurosurgery. 2010;67(5):1350–7. discussion 1357–8.

    Article  PubMed  Google Scholar 

  68. Rosenblum B, Oldfield EH, Doppman JL, Di Chiro G. Spinal arteriovenous malformations: a comparison of dural arteriovenous fistulas and intradural AVM’s in 81 patients. J Neurosurg. 1987;67(6): 795–802.

    Article  CAS  PubMed  Google Scholar 

  69. Miyasaka Y, Yada K, Ohwada T, Kitahara T, Kurata A, Irikura K. An analysis of the venous drainage system as a factor in hemorrhage from arteriovenous malformations. J Neurosurg. 1992;76(2):239–43.

    Article  CAS  PubMed  Google Scholar 

  70. Aviv RI, Shad A, Tomlinson G, et al. Cervical dural arteriovenous fistulae manifesting as subarachnoid hemorrhage: report of two cases and literature review. AJNR Am J Neuroradiol. 2004;25(5):854–8.

    PubMed  Google Scholar 

  71. Narisawa A, Endo T, Sato K, Watanabe M, Takahashi A, Tominaga T. Spinal dural arteriovenous shunt presenting with intramedullary hemorrhage: case report. J Neurosurg Spine. 2014;20(3):322–6.

    Article  PubMed  Google Scholar 

  72. Liu Z, Jiao Q, Xu J, Wang X, Li S, You C. Spontaneous spinal epidural hematoma: analysis of 23 cases. Surg Neurol. 2008;69(3):253–60.

    Article  PubMed  Google Scholar 

  73. Sandalcioglu IE, Wiedemayer H, Gasser T, Asgari S, Engelhorn T, Stolke D. Intramedullary spinal cord cavernous malformations: clinical features and risk of hemorrhage. Neurosurg Rev. 2003;26(4):253–6.

    Article  PubMed  Google Scholar 

  74. Schulman S, Beyth RJ, Kearon C, Levine MN. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2008;133(6 Suppl):257S–98.

    Article  CAS  PubMed  Google Scholar 

  75. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet. 1997;349(9065):1569–81.

    Article  Google Scholar 

  76. Chai-Adisaksopha C, Crowther M, Isayama T, Lim W. The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis. Blood. 2014;124(15):2450–8.

    Article  CAS  PubMed  Google Scholar 

  77. Fang MC, Go AS, Chang Y, et al. Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med. 2007;120(8):700–5.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 suppl):e195S–226.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Avorn J, Winkelmayer WC. Comparing the costs, risks, and benefits of competing strategies for the primary prevention of venous thromboembolism. Circulation. 2004;110(24 Suppl 1):IV25–32.

    PubMed  Google Scholar 

  80. Koch A, Ziegler S, Breitschwerdt H, Victor N. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: meta-analysis based on original patient data. Thromb Res. 2001;102(4):295–309.

    Article  CAS  PubMed  Google Scholar 

  81. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 suppl):e227S–77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Iorio A, Agnelli G. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med. 2000;160(15):2327–32.

    Article  CAS  PubMed  Google Scholar 

  83. Barritt D, Jordan S. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet. 1960;275(7138):1309–12.

    Article  Google Scholar 

  84. Kernohan R, Todd C. Heparin therapy in thromboembolic disease. Lancet. 1966;287(7438):621–3.

    Article  Google Scholar 

  85. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 suppl):e419S–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Hulle T, Kooiman J, Exter P, et al. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta‐analysis. J Thromb Haemost. 2014;12(3):320–8.

    Article  PubMed  CAS  Google Scholar 

  87. Kearon C. Natural history of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I22–30.

    PubMed  Google Scholar 

  88. Lagerstedt C, Fagher B, Olsson C, Öqvist B, Albrechtsson U. Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet. 1985;326(8454):515–8.

    Article  Google Scholar 

  89. Flinterman L, Van Der Meer F, Rosendaal F, Doggen C. Current perspective of venous thrombosis in the upper extremity. J Thromb Haemost. 2008;6(8): 1262–6.

    Article  CAS  PubMed  Google Scholar 

  90. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med. 1992;326(19):1240–5.

    Article  CAS  PubMed  Google Scholar 

  91. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the international cooperative pulmonary embolism registry (ICOPER). Lancet. 1999;353(9162):1386–9.

    Article  CAS  PubMed  Google Scholar 

  92. Stein PD, Henry JW. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest. 1995;108(4):978–81.

    Article  CAS  PubMed  Google Scholar 

  93. Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110(9): 1042–6.

    Article  PubMed  Google Scholar 

  94. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21): e1–76.

    Article  PubMed  Google Scholar 

  95. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983–8.

    Article  CAS  PubMed  Google Scholar 

  96. You JJ, Singer DE, Howard PA, et al. Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 suppl):e531S–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Baudet EM, Puel V, McBride JT, et al. Long-term results of valve replacement with the St. Jude medical prosthesis. J Thorac Cardiovasc Surg. 1995;109(5):858–70.

    Article  CAS  PubMed  Google Scholar 

  98. Hering D, Piper C, Bergemann R, et al. Thromboembolic and bleeding complications following St. Jude medical valve replacement: results of the German experience with low-intensity anticoagulation study. Chest. 2005;127(1):53–9.

    Article  PubMed  Google Scholar 

  99. Whitlock RP, Sun JC, Fremes SE, et al. Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 suppl):e576S–600.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Eikelboom JW, Connolly SJ, Brueckmann M, et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369(13): 1206–14.

    Article  CAS  PubMed  Google Scholar 

  101. Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362(23):2155–65.

    Article  CAS  PubMed  Google Scholar 

  102. Savonitto S, Ardissino D, Granger CB, et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA. 1999;281(8): 707–13.

    Article  CAS  PubMed  Google Scholar 

  103. Théroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med. 1988;319(17):1105–11.

    Article  PubMed  Google Scholar 

  104. Eikelboom JW, Anand SS, Malmberg K, et al. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis. Lancet. 2000;355(9219): 1936–42.

    Article  CAS  PubMed  Google Scholar 

  105. Harrington RA, Becker RC, Cannon CP, et al. Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2008;133(6 suppl):670S–707.

    Article  CAS  PubMed  Google Scholar 

  106. Alonso-Coello P, Bellmunt S, McGorrian C, et al. Antithrombotic therapy in peripheral artery disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 suppl):e669S–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Berridge DC, Kessel DO, Robertson I. Surgery versus thrombolysis for initial management of acute limb ischaemia. Cochrane Database Syst Rev. 2002;6, CD002784.

    Google Scholar 

  108. Bauer KA. The thrombophilias: well-defined risk factors with uncertain therapeutic implications. Ann Intern Med. 2001;135(5):367–73.

    Article  CAS  PubMed  Google Scholar 

  109. Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA. 2006;295(9):1050–7.

    Article  CAS  PubMed  Google Scholar 

  110. Schulman S, Svenungsson E, Granqvist S. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Am J Med. 1998;104(4):332–8.

    Article  CAS  PubMed  Google Scholar 

  111. Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65(4):476–83.

    Article  CAS  PubMed  Google Scholar 

  112. Sarwar M, McCormick W. Intracerebral venous angioma. Case report and review. Arch Neurol. 1978;35:323–5.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Stritch School of Medicine, Loyola University Chicago, 2160 S. First Avenue, Maywood, IL, USA

    Christopher P. Robinson D.O., M.S., Michael Star M.D. & José Biller M.D., F.A.C.P., F.A.A.N.

Authors
  1. Christopher P. Robinson D.O., M.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Star M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. José Biller M.D., F.A.C.P., F.A.A.N.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Star M.D. .

Editor information

Editors and Affiliations

  1. Stritch School of Medicine, Loyola University, Maywood, Illinois, USA

    Christopher M. Loftus

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Robinson, C.P., Star, M., Biller, J. (2016). Can Patients with Known Intracranial and Intraspinal Vascular Lesions Be Anticoagulated?. In: Loftus, C. (eds) Anticoagulation and Hemostasis in Neurosurgery. Springer, Cham. https://doi.org/10.1007/978-3-319-27327-3_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27327-3_26

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27325-9

  • Online ISBN: 978-3-319-27327-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation